Elucid Raises $55M Series D to Expand AI-Powered Cardiovascular Imaging Platform

Boston, MA, September 8, 2026 (MedTech Dive) -- Elucid has raised $55 million in Series D financing to commercialize its cardiovascular imaging technology and expand partnerships with medical device companies. The company plans to use the funding to scale its clinical decision platform, including Plaque-IQ, which creates 3D models from coronary CT scans to analyze arterial plaque, and its FFR-CT technology currently under FDA review. The financing brings Elucid’s total funding to approximately $185 million and includes backing from new and existing investors, including IAG Capital Partners and Elevage Medical Technologies.

Read full article here.